Cite
HARVARD Citation
Andrikopoulou, A. et al. (2023). Pembrolizumab in combination with bevacizumab and oral cyclophosphamide in heavily pre-treated platinum-resistant ovarian cancer. International journal of gynecological cancer. 33 (4), pp. 571-576. [Online].